Last reviewed · How we verify

NCT06777355: LIFESAVE

Association Between Portal Flow Pulsatility and Right Ventricular Dysfunction in the Postoperative Period of Cardiac Surgery

Completed Last updated 1 December 2025
What this trial tests

trial testing Transthoracic and Transesophageal echography within 24 hours post cardiac surgery in Postoperative Complications in 32 participants. Completed in 4 July 2025.

Timeline
24 February 2025
Primary endpoint
4 July 2025
4 July 2025

Quick facts

Lead sponsorCMC Ambroise Paré
StatusCompleted
Study typeOBSERVATIONAL
Enrollment32
Start date24 February 2025
Primary completion4 July 2025
Estimated completion4 July 2025
Sites1 location across France

Drugs / interventions tested

Conditions studied

Sponsor

CMC Ambroise Paré — full company profile →

Who can join

18 and older, any sex, with Postoperative Complications or Heart Failure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Right ventricular dysfunction (RVD) after cardiac surgery is associated with ischemia and myocardial injury. While echocardiographic measures like Tricuspid Annular Plane Systolic Excursion (TAPSE) are frequently used to assess ventricular function, they have limitations in terms of accuracy. The pulmonary artery catheter remains the gold standard for assessing RVD. This dysfunction is associated with an increased risk of both renal and hepatic failure, complications that significantly affect patient outcomes. Doppler ultrasound has emerged as a valuable tool in predicting these complications, particularly in monitoring portal circulation and hepatic perfusion. This study aims to explore the association between portal flow pulsatility and RVD after cardiac surgery.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Postoperative Complications

Currently open trials in the same condition.

Other CMC Ambroise Paré trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06777355.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing